US states drop Medicaid coverage of GLP-1 weight-loss drugs as demand rises | US healthcare

Faced with high demand for GLP-1 drugs, some American cities and states that previously covered the cost of the weight-loss medication for low-income residents and public employees have now started to restrict or eliminate coverage.

The pullback…